Australian Investing Ideas

Global Weekly Picks

US$7.43
FV
52.8% undervalued intrinsic discount
36.80%
Revenue growth p.a.
3k
users have viewed this narrative
15users have liked this narrative
0users have commented on this narrative
69users have followed this narrative
CA$1.81
FV
68.5% undervalued intrinsic discount
7.00%
Revenue growth p.a.
852
users have viewed this narrative
3users have liked this narrative
0users have commented on this narrative
22users have followed this narrative
AU$2.89
80.6% undervalued intrinsic discount
Fair Value
Revenue
7.82% p.a.
Profit Margin
9.26%
Future PE
6.79x
Price in 2030
AU$4.4
COH logo
Cochlear

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

Cochlear Limited is an interesting company. It is a medical technology business with a specific focus on implantable hearing solutions.Read more

View narrative
AU$70
35.4% overvalued intrinsic discount
Fair Value
Revenue
0.14% p.a.
Profit Margin
14.77%
Future PE
18.92x
Price in 2031
AU$100.4
AU$58
8.9% undervalued intrinsic discount
Fair Value
Revenue
N/A
Profit Margin
2%
Future PE
1x
Price in 2031
AU$0
AU$0.51
53.9% undervalued intrinsic discount
Profit Margin
12.92%
Future PE
19.75x
Price in 2029
AU$1.19
AU$1.75
50.6% undervalued intrinsic discount
Fair Value
Revenue
4.41% p.a.
Profit Margin
7.46%
Future PE
17x
Price in 2031
AU$2.48
AU$15.1
30.7% undervalued intrinsic discount
Fair Value
Revenue
14.81% p.a.
Profit Margin
30%
Future PE
30x
Price in 2031
AU$24.45
AU$0.4
27.5% undervalued intrinsic discount
Revenue
23.43% p.a.
Profit Margin
13.79%
Future PE
8.55x
Price in 2029
AU$0.51